This clinical trial is focused on studying the effects of a medication called methadone in patients who have experienced a hip fracture. Hip fractures are breaks in the upper part of the thigh bone, often occurring in older adults. The trial aims to understand how a single dose of methadone, given during surgery, compares to a placebo in managing pain for these patients.
Participants in the study will receive either methadone or a placebo intravenously, which means the medication is delivered directly into a vein. The study will observe various aspects of recovery, such as the need for additional pain medication, the ability to stand and move, and any side effects like nausea or constipation. The goal is to see if methadone can effectively reduce pain and improve recovery after hip fracture surgery.
The trial is part of a larger research effort called the MetaHip trial and is expected to continue until 2025. By participating, researchers hope to gather valuable information that could improve pain management strategies for elderly patients undergoing hip fracture surgery.



Denmark